This information was published on 2026-01-12T11:26 for IP Right Registration Published.
| Field | Value |
| (210) | 2569634 (IR 1866123) |
| (220) |
28 May 2025
|
| (300) |
US, 20 Dec 2024, 98915361
|
| (511) (510) |
Class 42
Biological research; biological research and analysis; development of gene-based medicines; gene therapy research; laboratory research services in the field of gene expression; medical research; medical research services; research in the field of gene editing technology; research in the field of synthetic biology; software as a service (SaaS) services featuring software using artificial intelligence (AI) for engaging in biological, medical, and gene therapy research; software as a service (SaaS) services, namely, hosting software for use by others for engaging in biological, medical, and gene therapy research; providing laboratory research services in the field of gene expression, namely, cancer biology; testing, inspection, research, or development of pharmaceutical preparations for gene therapy. |
| (540) | ASYMPTOTE GENETIC MEDICINES |
| (550) | Word |
| (730) |
Asymptote Genetic Medicines, Inc.
|
| (750) |
Franke Hyland Pty Ltd
|
Find out more about publications on the About page.